Remove Leveraging Remove Liabilities Remove Prospects
article thumbnail

Tremor International (TRMR) Q3 2024 Earnings Call Transcript

The Motley Fool

Since early 2024, we achieved significantly better results than in 2023 as our business, sales teams, and markets is on better footing, as evidenced by our ability to generate record Q3 results and accelerate our growth prospects by winning partnerships with some of the world's top companies. within their programmatic platform.

article thumbnail

Carnival Corp. (CCL) Q4 2024 Earnings Call Transcript

The Motley Fool

I have never been more excited about these prospects as we begin to unfold this multiyear strategy with the opening of Celebration Key in just about six months. times net debt to EBITDA, closing in on our expectation to reach investment-grade leverage metrics in 2026. Our current 2025 guidance will put us at 3.8 We ended 2024 with $27.5

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prudential Financial (PRU) Q3 2024 Earnings Call Transcript

The Motley Fool

On the institutional side, our continued leadership in pension risk transfer was reinforced through a second transaction with IBM, this time to reinsure $6 billion of pension liabilities. We also maintain a well-diversified, high-quality portfolio and disciplined approach to asset liability management.

article thumbnail

First Solar (FSLR) Q3 2024 Earnings Call Transcript

The Motley Fool

As disclosed earlier in the third quarter, First Solar also possesses a TOPCon patent portfolio through our acquisition of TetraSun in 2013, which we have begun to leverage as part of our ongoing efforts to develop the next generation of PV technologies. Have you fully remediated the backdrop here around the $50 million warranty liability?

Taxes 246
article thumbnail

2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now

The Motley Fool

Takeda's low valuation reflects a handful of important risks, such as key patent headwinds for top-selling drugs like Vyvanse, along with the company's highly leveraged balance sheet. Large-cap pharma stocks, after all, trade at an average earnings multiple of 15.1.

article thumbnail

Time to Pounce: 2 Electrifying Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in August

The Motley Fool

While these are tangible headwinds that current and prospective AT&T investors shouldn't ignore, they lack the gravity needed to really weigh on the company's stock for an extended period. There's no doubt that AT&T's dividend is safe with its leverage declining. As for the WSJ report, AT&T has refuted the findings.

article thumbnail

Booking Holdings (BKNG) Q4 2024 Earnings Call Transcript

The Motley Fool

Adapting to and leveraging new technologies has been in our DNA from the start, and generative AI is pushing the pace of technology innovation faster than ever. in the fourth quarter was up versus last year by about 320 basis points due primarily to leverage from adjusted fixed operating expenses and marketing expenses.